unPAUSED with Dr. Mary Claire HaverThe Testosterone Conversation with Dr. Kelly Casperson: Beyond Libido

Only 7% treated in Medicare

50:09–50:51 · 43s

Despite diagnosis of GSM, just 7% of U.S. Medicare patients received vaginal estrogen—underscoring a massive treatment failure.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.